M Holdings Securities, Inc. Organon & Co. Transaction History

M Holdings Securities, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$21.42 - $32.08 $53,956 - $80,809	-2,519 Reduced 16.77%	12,504 $294,000
Q4 2022 Feb 10, 2023	SELL	$23.31 - $28.61 $18,997 - $23,317	-815 Reduced 5.15%	15,023 $420,000
Q3 2022 Nov 16, 2022	BUY	$23.4 - $34.25 $3,627 - $5,308	155 Added 0.99%	15,838 $371,000
Q2 2022 Aug 16, 2022	SELL	$31.66 - $38.9 $12,822 - $15,754	-405 Reduced 2.52%	15,683 $529,000
Q1 2022 May 24, 2022	BUY	$30.45 - $39.36 $60,412 - $78,090	1,984 Added 14.07%	16,088 $562,000
Q2 2021 Aug 19, 2021	BUY	$28.45 - $38.0 $401,258 - $535,952	14,104 New	14,104 $427,000

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.89B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of M Holdings Securities, Inc., based on Form 13F filings with the SEC.

Stay updated on M Holdings Securities, Inc. with notifications on news.